S&P 500   4,286.76 (-0.03%)
DOW   33,403.12 (-0.31%)
QQQ   359.97 (+0.47%)
AAPL   173.04 (+1.07%)
MSFT   317.43 (+0.53%)
META   304.82 (+1.54%)
GOOGL   132.80 (+1.48%)
AMZN   128.21 (+0.86%)
TSLA   246.06 (-1.66%)
NVDA   446.38 (+2.62%)
NIO   8.80 (-2.65%)
BABA   86.27 (-0.54%)
AMD   103.31 (+0.48%)
T   14.95 (-0.47%)
F   12.38 (-0.32%)
MU   68.77 (+1.09%)
CGC   0.77 (-1.70%)
GE   110.18 (-0.33%)
DIS   80.91 (-0.17%)
AMC   8.33 (+4.26%)
PFE   33.37 (+0.60%)
PYPL   59.25 (+1.35%)
NFLX   380.49 (+0.77%)
S&P 500   4,286.76 (-0.03%)
DOW   33,403.12 (-0.31%)
QQQ   359.97 (+0.47%)
AAPL   173.04 (+1.07%)
MSFT   317.43 (+0.53%)
META   304.82 (+1.54%)
GOOGL   132.80 (+1.48%)
AMZN   128.21 (+0.86%)
TSLA   246.06 (-1.66%)
NVDA   446.38 (+2.62%)
NIO   8.80 (-2.65%)
BABA   86.27 (-0.54%)
AMD   103.31 (+0.48%)
T   14.95 (-0.47%)
F   12.38 (-0.32%)
MU   68.77 (+1.09%)
CGC   0.77 (-1.70%)
GE   110.18 (-0.33%)
DIS   80.91 (-0.17%)
AMC   8.33 (+4.26%)
PFE   33.37 (+0.60%)
PYPL   59.25 (+1.35%)
NFLX   380.49 (+0.77%)
S&P 500   4,286.76 (-0.03%)
DOW   33,403.12 (-0.31%)
QQQ   359.97 (+0.47%)
AAPL   173.04 (+1.07%)
MSFT   317.43 (+0.53%)
META   304.82 (+1.54%)
GOOGL   132.80 (+1.48%)
AMZN   128.21 (+0.86%)
TSLA   246.06 (-1.66%)
NVDA   446.38 (+2.62%)
NIO   8.80 (-2.65%)
BABA   86.27 (-0.54%)
AMD   103.31 (+0.48%)
T   14.95 (-0.47%)
F   12.38 (-0.32%)
MU   68.77 (+1.09%)
CGC   0.77 (-1.70%)
GE   110.18 (-0.33%)
DIS   80.91 (-0.17%)
AMC   8.33 (+4.26%)
PFE   33.37 (+0.60%)
PYPL   59.25 (+1.35%)
NFLX   380.49 (+0.77%)
S&P 500   4,286.76 (-0.03%)
DOW   33,403.12 (-0.31%)
QQQ   359.97 (+0.47%)
AAPL   173.04 (+1.07%)
MSFT   317.43 (+0.53%)
META   304.82 (+1.54%)
GOOGL   132.80 (+1.48%)
AMZN   128.21 (+0.86%)
TSLA   246.06 (-1.66%)
NVDA   446.38 (+2.62%)
NIO   8.80 (-2.65%)
BABA   86.27 (-0.54%)
AMD   103.31 (+0.48%)
T   14.95 (-0.47%)
F   12.38 (-0.32%)
MU   68.77 (+1.09%)
CGC   0.77 (-1.70%)
GE   110.18 (-0.33%)
DIS   80.91 (-0.17%)
AMC   8.33 (+4.26%)
PFE   33.37 (+0.60%)
PYPL   59.25 (+1.35%)
NFLX   380.49 (+0.77%)

Privia Health Group (PRVA) Stock Forecast, Price & News

$22.55
-0.45 (-1.96%)
(As of 10:03 AM ET)
Compare
Today's Range
$22.38
$22.95
50-Day Range
$21.63
$27.92
52-Week Range
$20.64
$36.55
Volume
65,549 shs
Average Volume
1.20 million shs
Market Capitalization
$2.65 billion
P/E Ratio
83.52
Dividend Yield
N/A
Price Target
$36.86

Privia Health Group MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
64.7% Upside
$36.86 Price Target
Short Interest
Bearish
5.86% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.88mentions of Privia Health Group in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$5.23 M Sold Last Quarter
Proj. Earnings Growth
31.82%
From $0.22 to $0.29 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.85 out of 5 stars

Medical Sector

60th out of 969 stocks

Health Services Industry

1st out of 12 stocks


PRVA stock logo

About Privia Health Group (NASDAQ:PRVA) Stock

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.

PRVA Price History

PRVA Stock News Headlines

Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
4 Analysts Have This to Say About Privia Health Gr
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
Privia Health to Enter Washington State
Privia Health Group (PRVA) Receives a Buy from RBC Capital
Privia Health Group (PRVA) Receives a Buy from Truist Financial
Privia Health Group (PRVA) Gets a Buy from Credit Suisse
See More Headlines
Receive PRVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Privia Health Group and its competitors with MarketBeat's FREE daily newsletter.

PRVA Company Calendar

Last Earnings
8/03/2023
Today
10/02/2023
Next Earnings (Estimated)
11/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Health services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PRVA
Fax
N/A
Employees
964
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$36.86
High Stock Price Forecast
$43.00
Low Stock Price Forecast
$28.00
Forecasted Upside/Downside
+60.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
10 Analysts

Profitability

Net Income
$-8,590,000.00
Pretax Margin
1.02%

Debt

Sales & Book Value

Annual Sales
$1.36 billion
Book Value
$4.53 per share

Miscellaneous

Free Float
64,784,000
Market Cap
$2.70 billion
Optionable
Not Optionable
Beta
0.85
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Parth MehrotraMr. Parth Mehrotra (Age 44)
    CEO & Director
    Comp: $1.37M
  • Mr. David Mountcastle CPAMr. David Mountcastle CPA (Age 52)
    MBA, Exec. VP, CFO & Principal Accounting Officer
    Comp: $882.07k
  • Mr. Thomas BartrumMr. Thomas Bartrum (Age 56)
    Exec. VP & Gen. Counsel
    Comp: $608.79k
  • Mr. Chris Voigt
    Exec. VP & Chief Technology Officer
  • Mr. Robert P. Borchert
    Sr. VP of Investor Relations & Corp. Communications
  • Ms. Dana Fields CPA
    Sr. VP of Internal Audit & Chief Compliance Officer
  • Ms. Jenny Harding
    Sr. VP of People Operations
  • Mr. Jay Stevens
    Sr. VP & Chief Growth Officer
  • Dr. S. Mark Cone FACOG (Age 60)
    M.D., Pres of Privia Medical Group - Gulf Coast Texas
  • Mr. Eric J. Beyer
    Exec. VP of Medical Groups













PRVA Stock - Frequently Asked Questions

Should I buy or sell Privia Health Group stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Privia Health Group in the last year. There are currently 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PRVA shares.
View PRVA analyst ratings
or view top-rated stocks.

What is Privia Health Group's stock price forecast for 2023?

10 equities research analysts have issued twelve-month price targets for Privia Health Group's stock. Their PRVA share price forecasts range from $28.00 to $43.00. On average, they predict the company's share price to reach $36.86 in the next twelve months. This suggests a possible upside of 60.2% from the stock's current price.
View analysts price targets for PRVA
or view top-rated stocks among Wall Street analysts.

How have PRVA shares performed in 2023?

Privia Health Group's stock was trading at $22.71 at the beginning of the year. Since then, PRVA stock has increased by 1.3% and is now trading at $23.00.
View the best growth stocks for 2023 here
.

When is Privia Health Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our PRVA earnings forecast
.

How were Privia Health Group's earnings last quarter?

Privia Health Group, Inc. (NASDAQ:PRVA) issued its quarterly earnings data on Thursday, August, 3rd. The company reported $0.06 EPS for the quarter, topping analysts' consensus estimates of $0.05 by $0.01. The firm earned $413.35 million during the quarter, compared to the consensus estimate of $392.34 million. Privia Health Group had a net margin of 2.26% and a trailing twelve-month return on equity of 6.36%.

What guidance has Privia Health Group issued on next quarter's earnings?

Privia Health Group updated its FY 2023 earnings guidance on Thursday, August, 3rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.60 billion-$1.65 billion, compared to the consensus revenue estimate of $1.61 billion.

When did Privia Health Group IPO?

(PRVA) raised $351 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 19,500,000 shares at a price of $17.00-$19.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse, Piper Sandler and William Blair acted as the underwriters for the IPO and Canaccord Genuity, Truist Securities, R. Seelaus & Co. and Siebert Williams Shank were co-managers.

What is Privia Health Group's stock symbol?

Privia Health Group trades on the NASDAQ under the ticker symbol "PRVA."

How do I buy shares of Privia Health Group?

Shares of PRVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Privia Health Group's stock price today?

One share of PRVA stock can currently be purchased for approximately $23.00.

How much money does Privia Health Group make?

Privia Health Group (NASDAQ:PRVA) has a market capitalization of $2.70 billion and generates $1.36 billion in revenue each year. The company earns $-8,590,000.00 in net income (profit) each year or $0.27 on an earnings per share basis.

How many employees does Privia Health Group have?

The company employs 964 workers across the globe.

How can I contact Privia Health Group?

The official website for the company is www.priviahealth.com. The company can be reached via phone at 571-366-8850 or via email at ir@priviahealth.com.

This page (NASDAQ:PRVA) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -